As demonstrated in our previous report36, HeLa cell is a BCL-xL/2-independent cancer cell line, which can be used to test PROTACs (against BCL-xL/2) with minimized confounding effect of apoptosis on protein degradation. This evidence concerns the gene BCL2L1 and cancer.